12:00 AM
 | 
Dec 12, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Inecalcitol: Phase II started

Hybrigenics began a double-blind, placebo-controlled, French Phase II trial evaluating 4 mg/day inecalcitol for 16 weeks in about 60 patients with moderate to severe psoriasis. Hybrigenics...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >